A method of treating a human subject in need of treatment for cancer, comprising administering to the human subject an isolated antibody or antigen-binding fragment comprising a heavy chain variable region comprising three heavy chain complementary determining regions (HCDRs), wherein the sequence of HCDR1 is GYRLSELS (SEQ ID NO:
- 1), the sequence of HCDR2 is ISGWDGNT (SEQ ID NO:
- 2), and the sequence of HCDR3 is ARASGYNY(SEQ ID NO:
- 3), wherein the isolated antibody or antigen-binding fragment specifically binds human HSP90.